Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Current Opinion in Endocrinology, Diabetes, and Obesity|July 3, 2008
New antigenic targets in type 1 diabetesJanet M Wenzlau, John C Hutton, Howard W DavidsonDiabetes/Metabolism Research and Reviews|November 10, 2011
Mapping of conformational autoantibody epitopes in ZNT8Janet M Wenzlau, Lisa M Frisch, John C Hutton, et al.Diabetes Care|September 26, 2015
Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody WorkshopJanet M Wenzlau, Lisa M Frisch, John C Hutton, et al.Annals of the New York Academy of Sciences|January 6, 2009
Identification of a major humoral epitope in Slc30A8 (ZnT8)Janet M Wenzlau, Ong Moua, Yu Liu, et al.Current Diabetes Reports|August 1, 2013
Novel diabetes autoantibodies and prediction of type 1 diabetesJanet M Wenzlau, John C HuttonCurrent Diabetes Reports|March 28, 2009
Novel antigens in type 1 diabetes: the importance of ZnT8Janet M Wenzlau, Lisa M Frisch, Thomas J Gardner, et al.Trends in Endocrinology and Metabolism: TEM|April 23, 2014
Zinc transporter 8 (ZnT8) and β cell functionHoward W Davidson, Janet M Wenzlau, Richard M O'BrienJournal of Immunology (Baltimore, Md. : 1950)|April 8, 2011
Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8MyLinh Dang, Jennifer Rockell, Rebecca Wagner, et al.Annals of the New York Academy of Sciences|January 6, 2009
SlC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetesJanet M Wenzlau, Ong Moua, Suparna A Sarkar, et al.Diabetes|July 2, 2008
A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetesJanet M Wenzlau, Yu Liu, Liping Yu, et al.Pageof 9